Related Experiment Video
Updated: Jun 4, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Pharmacotherapy in pediatric sleep disorders
Shelly K Weiss1, Andrea Garbutt
1Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada. shelly.weiss@sickkids.ca
Pediatric sleep disorders impact learning and behavior. Treatment, including behavioral interventions and pharmacotherapy, requires accurate diagnosis and understanding of limited research, especially for adolescents.
Area of Science:
- Pediatric Sleep Medicine
- Pharmacology
- Child Psychology
Background:
- Sleep disorders are common in children and adolescents, affecting daytime functioning like learning, memory, attention, and behavior.
- Untreated sleep problems can lead to significant negative impacts on a child's development and daily life.
Purpose of the Study:
- To outline the pharmacologic treatment of sleep disorders in typically developing children and adolescents.
- To emphasize the importance of accurate diagnosis and understanding the role of pharmacotherapy.
Main Methods:
- Review of current literature on pediatric sleep disorders and their treatment.
- Discussion of the principles guiding pharmacotherapy and behavioral interventions.
- Focus on pharmacologic approaches for various pediatric sleep conditions.
Main Results:
- Behavioral interventions are effective for young children with insomnia, with less evidence for school-age children and adolescents.
- Pharmacotherapy for pediatric insomnia is not well-defined, often relying on adult data and off-label use.
- Specific sleep disorders beyond insomnia may warrant pharmacotherapy combined with behavioral strategies.
Conclusions:
- Accurate diagnosis is crucial for effective treatment of pediatric sleep disorders.
- Non-pharmacologic strategies are generally the first line of treatment, especially for insomnia.
- Further research is needed on pharmacotherapy for sleep disorders in pediatric populations.
More Related Videos
07:54Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Management of Insomnia
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution